Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1998-07-23
2000-02-08
Moezie, F. T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 530399, 530397, 530362, 530363, 530324, 435 691, A61K 3827
Patent
active
06022858&
ABSTRACT:
A pharmaceutical formulation comprising a growth hormone pretreated with zinc and optionally lysine or calcium ions shows a very high stability against deamidation, oxidation and cleavage of peptide bonds. The stability of the product allows for the storing and shipment thereof in a lyophilized state or in the form of a dissolved or re-dissolved formulation at ambient temperature.
REFERENCES:
patent: 4816568 (1989-03-01), Hamilton, Jr. et al.
patent: 4917685 (1990-04-01), Viswanathan et al.
patent: 5023088 (1991-06-01), Wong et al.
patent: 5045312 (1991-09-01), Aston et al.
patent: 5547696 (1996-08-01), S.o slashed.rensen
patent: 5552385 (1996-09-01), Christensen et al.
patent: 5631225 (1997-05-01), S.o slashed.rensen
patent: 5654278 (1997-08-01), S.o slashed.rensen
patent: 5705482 (1998-01-01), Christensen et al.
patent: 5849700 (1998-12-01), S.o slashed.rensen
patent: 5849704 (1998-12-01), S.o slashed.rensen
patent: 5851992 (1998-12-01), S.o slashed.rensen
Gellerfors et al., Acta P.ae butted.diatr Scand [Suppl], vol. 370, pp. 93-100 (1990).
Kaufman, Pharmaceutical Research, vol. 7, No. 3, pp. 289-292 (1990).
Becker et al., Biotech. and Applied Biochem., vol. 9, pp. 478-487 (1987).
Arthur Osol ed., Mack Publishing Co., Easton, PA, Remington's Pharmaceutical Sciences, 16th ed., pp. 1535 (1980).
Wang et al., J. of Parenteral Science and Technology, vol. 42, p. S3-S27, 1988.
Jensen et al., Biotech. and Bioengineering, vol. 36, No. 1, p. 1-11, 1990.
Yu-Chang et al., J. Parent. Sci. & Tech., vol. 42, pp. S3-S26 (1988).
Manning et al., Pharmaceutical Research, vol. 6, No. 11, pp. 903-918 (1989).
Johnson et al., The Journal of Biological Chemistry, vol. 264, No. 24, pp. 14262-14271 (1989).
Liew-Cheng Teh et al., J. of Biol. Chem., vol. 262, No. 14, pp. 6472-6477 (1987).
Becker et al., Biotech. and App. Biochem., vol. 10, pp. 326-337 (1988).
Houghten et al., Arch. of Biochem. Biophysics, vol. 178, pp. 350-355 (1977).
Riggen et al., Analytical Biochem., vol. 167, pp. 199-209 (1987).
Balschmidt Per
Olsen Ole Hvilsted
S.o slashed.rensen Hans Holmegaard
Thim Lars
Thorkild Christensen
Agris Cheryl H.
Moezie F. T.
Novo Nordisk A S
Zelson Steve T.
LandOfFree
Pharmaceutical formulation of human-growth hormone pretreated wi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical formulation of human-growth hormone pretreated wi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical formulation of human-growth hormone pretreated wi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1681578